BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Prognosis
9 results:

  • 1. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
    Xu K; Xia P; Chen X; Ma W; Yuan Y
    Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor prognosis in Hepatocellular Carcinoma.
    Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
    Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systemic Therapy for Metastatic pancreatic cancer.
    Ettrich TJ; Seufferlein T
    Curr Treat Options Oncol; 2021 Oct; 22(11):106. PubMed ID: 34665339
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ablation of 5-lipoxygenase mitigates pancreatic lesion development.
    Knab LM; Schultz M; Principe DR; Mascarinas WE; Gounaris E; Munshi HG; Grippo PJ; Bentrem DJ
    J Surg Res; 2015 Apr; 194(2):481-487. PubMed ID: 25454978
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.
    Bjerregaard JK; Mortensen MB; Jensen HA; Nielsen M; Pfeiffer P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):909-15. PubMed ID: 22172900
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic factors of pancreatic cancer can be different according to clinical stages.
    Kim YJ; Seo DW; Pack KM; Jeong E; Kim SC; Han DJ; Lee SS; Lee SK; Kim MH
    Korean J Gastroenterol; 2008 Mar; 51(3):181-9. PubMed ID: 18451692
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
    Kleeff J; Michalski CW; Friess H; Büchler MW
    Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma.
    Oettle H; Arnold D; Esser M; Huhn D; Riess H
    Anticancer Drugs; 2000 Sep; 11(8):635-8. PubMed ID: 11081455
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chemotherapy in advanced pancreatic cancer.
    Dippold W; Bernhard H; Meyer zum Büschenfelde KH
    Int J Pancreatol; 1997 Feb; 21(1):39-41. PubMed ID: 9127172
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.